| Year |
Citation |
Score |
| 2016 |
Carnemolla R, Villa CH, Greineder CF, Zaitsev S, Patel KR, Kowalska MA, Atochin DN, Cines DB, Siegel DL, Esmon CT, Muzykantov VR. Targeting thrombomodulin to circulating red blood cells augments its protective effects in models of endotoxemia and ischemia-reperfusion injury. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 27836986 DOI: 10.1096/Fj.201600912R |
0.365 |
|
| 2015 |
Greineder CF, Brenza JB, Carnemolla R, Zaitsev S, Hood ED, Pan DC, Ding BS, Esmon CT, Chacko AM, Muzykantov VR. Dual targeting of therapeutics to endothelial cells: collaborative enhancement of delivery and effect. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 25953848 DOI: 10.1096/Fj.15-271213 |
0.444 |
|
| 2015 |
Villa CH, Greineder CF, Johnston I, Pan D, Carnemolla R, Cines DB, Poncz M, Siegel DL, Muzykantov VR. Thrombomodulin Fusion Proteins Coupled to Human Erythrocytes Demonstrate Anti-Thrombotic and Anti-Inflammatory Activity Blood. 126: 3493-3493. DOI: 10.1182/Blood.V126.23.3493.3493 |
0.43 |
|
| 2013 |
Greineder CF, Chacko AM, Zaytsev S, Zern BJ, Carnemolla R, Hood ED, Han J, Ding BS, Esmon CT, Muzykantov VR. Vascular immunotargeting to endothelial determinant ICAM-1 enables optimal partnering of recombinant scFv-thrombomodulin fusion with endogenous cofactor. Plos One. 8: e80110. PMID 24244621 DOI: 10.1371/Journal.Pone.0080110 |
0.449 |
|
| 2013 |
Carnemolla R, Greineder CF, Chacko AM, Patel KR, Ding BS, Zaitsev S, Esmon CT, Muzykantov VR. Platelet endothelial cell adhesion molecule targeted oxidant-resistant mutant thrombomodulin fusion protein with enhanced potency in vitro and in vivo. The Journal of Pharmacology and Experimental Therapeutics. 347: 339-45. PMID 23965383 DOI: 10.1124/Jpet.113.205104 |
0.403 |
|
| 2013 |
Greineder CF, Howard MD, Carnemolla R, Cines DB, Muzykantov VR. Advanced drug delivery systems for antithrombotic agents. Blood. 122: 1565-75. PMID 23798715 DOI: 10.1182/Blood-2013-03-453498 |
0.342 |
|
| 2012 |
Carnemolla R, Patel KR, Zaitsev S, Cines DB, Esmon CT, Muzykantov VR. Quantitative analysis of thrombomodulin-mediated conversion of protein C to APC: translation from in vitro to in vivo. Journal of Immunological Methods. 384: 21-4. PMID 22750541 DOI: 10.1016/J.Jim.2012.06.012 |
0.418 |
|
| 2012 |
Zaitsev S, Kowalska MA, Neyman M, Carnemolla R, Tliba S, Ding BS, Stonestrom A, Spitzer D, Atkinson JP, Poncz M, Cines DB, Esmon CT, Muzykantov VR. Targeting recombinant thrombomodulin fusion protein to red blood cells provides multifaceted thromboprophylaxis. Blood. 119: 4779-85. PMID 22493296 DOI: 10.1182/Blood-2011-12-398149 |
0.436 |
|
| 2012 |
Sontag TJ, Carnemolla R, Vaisar T, Reardon CA, Getz GS. Naturally occurring variant of mouse apolipoprotein A-I alters the lipid and HDL association properties of the protein. Journal of Lipid Research. 53: 951-63. PMID 22402133 DOI: 10.1194/Jlr.M021154 |
0.478 |
|
| 2011 |
Carnemolla R, Muzykantov VR. Vascular targeting of antithrombotic agents. Iubmb Life. 63: 632-9. PMID 21766410 DOI: 10.1002/Iub.474 |
0.327 |
|
| 2010 |
Carnemolla R, Shuvaev VV, Muzykantov VR. Targeting antioxidant and antithrombotic biotherapeutics to endothelium. Seminars in Thrombosis and Hemostasis. 36: 332-42. PMID 20490983 DOI: 10.1055/S-0030-1253455 |
0.336 |
|
| 2008 |
Carnemolla R, Ren X, Biswas TK, Meredith SC, Reardon CA, Wang J, Getz GS. The specific amino acid sequence between helices 7 and 8 influences the binding specificity of human apolipoprotein A-I for high density lipoprotein (HDL) subclasses: a potential for HDL preferential generation. The Journal of Biological Chemistry. 283: 15779-88. PMID 18385132 DOI: 10.1074/Jbc.M710244200 |
0.467 |
|
| Show low-probability matches. |